Connect with us
“What the courts will see is a drug that does not cure a disease or alleviate the symptoms of a disease,” said National Right to Life...
Health policy and legal experts warned that a federal judge’s decision last week to delay the FDA’s clearance of mifepristone may significantly undermine the agency. After...
